Study Finds Breast Cancers with Low Levels of HER2 Protein Are Not a Distinct Subtype of the Disease
UCSF Prostate Cancer Specialist Inducted into Annual Class of “Giants of Cancer Care”
HDR Brachytherapy for Clinically Localized Prostate Cancer
Dana-Farber/Boston Children's Again Named Top Pediatric Cancer Program
The New Lung Cancer Landscape
Improved Progression-Free Survival in Patients with Multiple Myeloma Following Three-Drug Therapy with Autologous Stem Cell Transplant
Roswell Park Presents ‘Highly Encouraging’ Phase 2A Results on SurVaxM Immunotherapy for Glioblastoma
Lung Cancer Therapy Could Help Patients Live Longer
From ASCO 2022: Brentuximab Vedotin and Chemotherapy an Effective Treatment for Hodgkin Lymphoma
Targeted Drug Achieves 43% Response Rate in KRAS-Mutated Lung Cancer
Roswell Park Expert to Present on Effectiveness of New Combination for Acute Myeloid Leukemia
Race, Ethnicity, and Poverty Linked to Worse Outcomes in Children Treated for High-Risk Neuroblastoma
Combination Therapy Produces Encouraging Results in Patients with Gynecologic Cancers with Distinct Genetic Mutations
Roswell Park Researchers Identify Molecular ‘Glue’ That Sticks to and Degrades a Cancer-Causing Protein
Preventing and Treating Cardiovascular Toxicity from Cancer Therapy
Showing 391 - 405 of 1027 results
Previous| 1... 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 ...69 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
